P.T.E. Postema

Radiotherapy with a Radiolabeled Somatostatin Analogue, [¹¹¹In‐DTPA‐<scp>d</scp>‐Phe¹]‐Octreotide

E. P. Krenning, P.P.M. Kooij, Willem H. Bakker et al. · Annals of the New York Academy of Sciences · 1994 · 310 citations · Full text

Medicine, Nuclear Medicine, Oncology +12

Somatostatin Receptor: Scintigraphy and Radionuclide Therapy

E. P. Krenning, P.P.M. Kooij, Stanislas Pauwels et al. · Digestion · 2009 · 129 citations

Medicine, Nuclear Medicine, Oncology +17

[111In-DTPA-D-Phe1] octreotide scintigraphy in thyroidal and orbital Graves' disease: a parameter for disease activity?

P.T.E. Postema, E. P. Krenning, R. Wijngaarde et al. · The Journal of Clinical Endocrinology & Metabolism · 1994 · 74 citations

Medicine, Endocrinology, Nuclear Medicine +17

Visualization of the thymus by substance P receptor scintigraphy in man

P. Martin van Hagen, Wout A. P. Breeman, Jean Claude Reubi et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1996 · 56 citations · Full text

Medicine, Nuclear Medicine, Physiology +7

Somatostatin Receptor Scintigraphy in Non-Medullary Thyroid Cancer

P.T.E. Postema, Wouter W. de Herder, Jean Claude Reubi et al. · Digestion · 2009 · 49 citations

Medicine, Nuclear Medicine, Radiology +17